CAMBIUM BIO LIMITED (CMB)
AI Coverage Rating: Active
ASX AI Signals has generated 5 signal for CMB during the last 90 days,
indicating active trading activity and ongoing AI monitoring
Latest CMB Signals |
| 29/06/2026 | SELL |
| 28/06/2026 | SELL |
| 27/06/2026 | SELL |
CMB Share Price |
| Current Price | $0.435 |
| 52 Week High | $0.600 |
| 52 Week Low: | $0.215 |
| Trading at (% of 52 Week High) | 72.50% |
Volume
8000
20 Day Avg
3118
Relative Volume
256.5%
Business Overview
Cambium Bio Limited (ASX: CMB) is a biotechnology company focused on developing innovative treatments for cancer and other diseases. The company leverages stem cell technology and advanced drug delivery systems to create new therapies. Cambium Bio aims to address unmet medical needs through its research and development programs.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The SELL recommendation for CAMBIUM BIO LIMITED (CMB) is supported by current market indicators and valuation concerns, suggesting a notable downside risk. However, moderate volatility and sector-specific catalysts introduce some uncertainty, warranting a high but not very high confidence level.
Latest CAMBIUM BIO LIMITED(CMB) News
13 Aug 2025, 12:30 AM
Custom Market Insights
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Veterinary Regenerative Medicine Market size & share revenue was valued at approximately USD 401.21 Million in 2024 and is expected to reach USD
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals,
advanced AI analysis, watchlists and email alerts.
14 Day Free Trial •
Cancel Anytime •
Founders Price $15/month
Start My Free Trial
